Fabrice Jardin

11.7k total citations
217 papers, 4.4k citations indexed

About

Fabrice Jardin is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Fabrice Jardin has authored 217 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Pathology and Forensic Medicine, 90 papers in Oncology and 70 papers in Genetics. Recurrent topics in Fabrice Jardin's work include Lymphoma Diagnosis and Treatment (146 papers), Chronic Lymphocytic Leukemia Research (63 papers) and Cancer Genomics and Diagnostics (41 papers). Fabrice Jardin is often cited by papers focused on Lymphoma Diagnosis and Treatment (146 papers), Chronic Lymphocytic Leukemia Research (63 papers) and Cancer Genomics and Diagnostics (41 papers). Fabrice Jardin collaborates with scholars based in France, United States and Germany. Fabrice Jardin's co-authors include Hervé Tilly, Philippe Ruminy, Christian Bastard, Sylvain Mareschal, Pierre Véra, Philìppe Bertrand, Élodie Bohers, Pierre‐Julien Viailly, Corinne Haïoun and Gilles Salles and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Fabrice Jardin

201 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fabrice Jardin France	37	2.6k	1.8k	1.1k	1.1k	655	217	4.4k
Mats Jerkeman Sweden	34	3.8k 1.5×	2.6k 1.5×	1.6k 1.5×	760 0.7×	358 0.5×	214	4.9k
Christiane De Wolf‐Peeters Belgium	36	2.0k 0.8×	1.5k 0.9×	674 0.6×	999 0.9×	594 0.9×	59	4.0k
Kieron Dunleavy United States	36	3.6k 1.4×	2.7k 1.5×	1.6k 1.4×	1.1k 1.0×	452 0.7×	149	5.6k
Thomas Rüdiger Germany	37	3.3k 1.3×	2.6k 1.4×	903 0.8×	723 0.7×	658 1.0×	93	5.0k
Dok Hyun Yoon South Korea	35	2.1k 0.8×	2.4k 1.3×	572 0.5×	603 0.6×	243 0.4×	303	4.3k
Lisa M. Rimsza United States	42	3.5k 1.4×	2.6k 1.5×	1.6k 1.4×	1.4k 1.3×	398 0.6×	199	6.2k
Brian Skinnider Canada	33	2.3k 0.9×	1.7k 1.0×	645 0.6×	752 0.7×	327 0.5×	70	3.8k
Marita Ziepert Germany	26	2.7k 1.0×	1.7k 1.0×	846 0.8×	492 0.5×	332 0.5×	101	3.4k
Mark Roschewski United States	25	1.4k 0.6×	1.3k 0.8×	627 0.6×	779 0.7×	549 0.8×	131	2.9k
Christiane Copie‐Bergman France	39	3.0k 1.2×	1.9k 1.1×	796 0.7×	387 0.4×	282 0.4×	119	4.4k

Countries citing papers authored by Fabrice Jardin

Since Specialization

Citations

This map shows the geographic impact of Fabrice Jardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Jardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Jardin more than expected).

Fields of papers citing papers by Fabrice Jardin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Jardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Jardin. The network helps show where Fabrice Jardin may publish in the future.

Co-authorship network of co-authors of Fabrice Jardin

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Jardin. A scholar is included among the top collaborators of Fabrice Jardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Jardin. Fabrice Jardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rives‐Feraille, Aurélie, Pascaline Etancelin, Fabrice Jardin, et al.. (2025). Detection of minimal residual disease in cryopreserved testicular tissue from (pre)pubertal boys with acute leukemia following first-line therapy. Human Reproduction. 40(8). 1476–1484.

Duplomb, Laurence, et al.. (2024). A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma. Journal of Experimental & Clinical Cancer Research. 43(1). 148–148. 3 indexed citations

Ahle, Guido, Émeline Tabouret, Roch Houot, et al.. (2024). Primary central nervous system lymphoma of the spinal cord: A LOC network cohort study. Revue Neurologique. 181(3). 200–209.

Taly, Antoine, Juliana C. Santos, Marcelo Lima Ribeiro, et al.. (2023). Exportin 1‐mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma. Molecular Oncology. 17(12). 2546–2564. 3 indexed citations

Camus, Vincent, Pascaline Etancelin, Fanny Drieux, et al.. (2023). Complete hematologic response after belinostat treatment and allogeneic stem cell transplantation for multiple relapsed/refractory angioimmunoblastic T‐cell lymphoma: A case report. SHILAP Revista de lepidopterología. 11(6). e7623–e7623. 2 indexed citations

Herrera, Alex F., Samuel Tracy, Laurie H. Sehn, et al.. (2023). CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE POLARIX STUDY. Hematological Oncology. 41(S2). 175–177. 1 indexed citations

Aoufouchi, Saïd, David Rizzo, Nathalie Faumont, et al.. (2023). IGH 3’RR recombination uncovers a non-germinal center imprint and c-MYC-dependent IGH rearrangement in unmutated chronic lymphocytic leukemia. Haematologica. 109(2). 466–478. 2 indexed citations

Maître, Elsa, Cécile Tomowiak, Fontanet Bijou, et al.. (2022). Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients. Cancers. 14(8). 1904–1904. 10 indexed citations

Gros, Audrey, B. Vergier, Marie Parrens, et al.. (2022). Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling. PLoS ONE. 17(4). e0266978–e0266978. 4 indexed citations

10.

Dubois, Sydney, Philippe Ruminy, Élodie Bohers, et al.. (2021). Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma. SHILAP Revista de lepidopterología. 9(8). e04504–e04504. 2 indexed citations

11.

Tedbirt, Billal, Sydney Dubois, Aspasia Stamatoullas, et al.. (2020). Multiple cutaneous ulcers revealing a primary cutaneous Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma. SHILAP Revista de lepidopterología. 8(12). 2578–2582. 3 indexed citations

12.

Sarkozy, Clémentine, Franck Morschhauser, Sydney Dubois, et al.. (2020). A LYSA Phase Ib Study of Tazemetostat (EPZ-6438) plus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) with Poor Prognosis Features. Clinical Cancer Research. 26(13). 3145–3153. 54 indexed citations

13.

Viailly, Pierre‐Julien, Thierry Lecroq, Élodie Bohers, et al.. (2020). UMI-VarCal: a new UMI-based variant caller that efficiently improves low-frequency variant detection in paired-end sequencing NGS libraries. Bioinformatics. 36(9). 2718–2724. 15 indexed citations

14.

Decazes, Pierre, Vincent Camus, Élodie Bohers, et al.. (2020). Correlations between baseline 18F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma. EJNMMI Research. 10(1). 120–120. 15 indexed citations

15.

Lian, Chunfeng, Su Ruan, Thierry Denœux, Fabrice Jardin, & Pierre Véra. (2016). Selecting radiomic features from FDG-PET images for cancer treatment outcome prediction. Medical Image Analysis. 32. 257–268. 54 indexed citations

16.

Cottereau, Anne‐Ségolène, Hélène Lanic, Sylvain Mareschal, et al.. (2016). Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma. Clinical Cancer Research. 22(15). 3801–3809. 132 indexed citations

17.

Loschi, Michaël, Ali N. Chamseddine, Nathalie Contentin, et al.. (2015). Invasive Aspergillosis in Neutropenic Patients During Hospital Renovation: Effectiveness of Mechanical Preventive Measures in a Prospective Cohort of 438 Patients. Mycopathologia. 179(5-6). 337–345. 13 indexed citations

18.

Zucca, Emanuele, Annarita Conconi, Daniele Laszlò, et al.. (2013). Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study. Journal of Clinical Oncology. 31(5). 565–572. 148 indexed citations

19.

Safar, Violaine, Jehan Dupuis, Emmanuel Itti, et al.. (2011). Interim [ ¹⁸ F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab. Journal of Clinical Oncology. 30(2). 184–190. 124 indexed citations

20.

Ruminy, Philippe, Fabrice Jardin, Philippe Gaulard, et al.. (2006). Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology. Oncogene. 25(35). 4947–4954. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact